SCHEMBL13710178

SCHEMBL13710178

Cc1sc(-c2cccc(Cl)c2)nc1C1=C(OC(=O)C(C)(C)C)CC(C)(C)CC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.41
▸ KMT2A Q03164 1/20 0.40
▸ TRPM8 Q7Z2W7 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.36
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CFTR P13569 2/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TRPV1 Q8NER1 2/20 0.34
▸ HCRTR1 O43613 1/20 0.33
▸ HCRTR2 O43614 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ RARA P10276 1/20 0.33
▸ RARB P10826 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13761051 0.86 HRH3 (0.40) HRH3KMT2ATRPM8ADORA3CA1
SCHEMBL13710172 0.82 KMT2A (0.44) HRH3KMT2ATRPM8ADORA3NPC1
SCHEMBL14506986 0.79 RARA (0.46) HRH3KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL13710244 0.76 LMNA (0.46) HRH3KMT2ATRPM8NPC1POLB
SCHEMBL13710203 0.76 RARA (0.43) HRH3KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL14064280 0.73 KMT2A (0.42) HRH3KMT2ATRPM8ADORA3NPC1
SCHEMBL10947384 0.72 ELANE (0.38) KMT2ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13710241 0.72 KMT2A (0.42) HRH3KMT2ATRPM8POLBKDM4E
SCHEMBL10946106 0.72 PGR (0.42) KMT2ACA1CA2HPGD
SCHEMBL13710181 0.71 RARA (0.46) HRH3TRPM8ALDH1A1RARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents DDT, CYP4B1, CYP1B1 HRH3 2958/4885KMT2A 2192/4885TRPM8 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback